Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





TRIBUTYL PHOSPHATE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 126-73-8; **Chemical Formula:** (C4H9)3PO4
The former OSHA standard for tributyl phosphate was 5 mg/m3 as an 8-hour TWA. The ACGIH has a 2.5-mg/m3 TWA for tributyl phosphate, which is a clear, colorless, odorless liquid. The proposed PEL was an 8-hour TWA of 2.5 mg/m3; NIOSH (Ex. 8-47, Table N1) concurs that this limit is appropriate. The final rule establishes an 8-hour TWA PEL of 2.5 mg/m3 for tributyl phosphate.
Tributyl phosphate’s toxicity affects the skin, mucous membranes, lungs, and central nervous system, and this substance is also a cholinesterase inhibitor.
A paper by Smyth and Carpenter (1944/Ex. 1-374) reported that contact with liquid tributyl phosphate caused severe eye injury and skin irritation when tested in rabbits. Chambers and Casida (1967/Ex. 1-305) found that mice injected with 1 g/kg tributyl phosphate intraperitoneally became paralyzed. A study by Vandekar (1957/Ex. 1-498) in which mice were given tributyl phosphate by gavage revealed that a dose of 80 mg/kg resulted in a one-hour period of anesthesia, and a dose of 100 mg/kg resulted in 8 to 10 minutes of anesthesia, followed by respiratory failure and death. Administered intraperitoneally to rats, tributyl phosphate inhibited cholinesterase activity and stimulated plasma beta-glucuronidase activity (Suzuki, Kikuchi, Kato et al. 1977/Ex. 1-1170). This substance did not exhibit mutagenic activity in bacterial or fruit fly assays (Hanna and Dyer 1975/Ex. 1-485).
Nausea and headache were reported by workers exposed to levels of 15 mg/m3 of tributyl phosphate (Mastromatteo 1964b, as cited in ACGIH 1986/Ex. 1-3, p. 591). No comments, other than NIOSH’s, were received on this substance.
In the final rule, OSHA is reducing the 8-hour PEL from 5 mg/m3 to 2.5 mg/m3. OSHA concludes that this limit will protect workers against the significant risk of paralysis, anesthetic effects, and skin or eye irritation, all of which constitute material impairments of health that are associated with exposure to tributyl phosphate at levels above the new PEL.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue